NCT02655380

Brief Summary

Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 14, 2016

Completed
1.4 years until next milestone

Study Start

First participant enrolled

June 19, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2018

Completed
Last Updated

January 10, 2019

Status Verified

January 1, 2019

Enrollment Period

10 months

First QC Date

January 8, 2016

Last Update Submit

January 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • acceptability of intubation condition

    For assessment of intubation condition, 5 variables will be individually evaluated though 3 point scale (excellent, good, poor). If all variables are graded as excellent, intubation condition will be excellent. If at least 1 variable is poor, it will be reported as poor. Otherwise, it will be reported as good. Good and excellent will be considered to be acceptable intubating condition. Poor will be reported as unacceptable intubating condition. 1. Laryngoscope easiness 2. Vocal cord position 3. Vocal cord movement 4. Movement of limb 5. Coughing

    during and after intubation, about 2 minute

Study Arms (2)

ketamine 1

EXPERIMENTAL

Anesthesia induction with ketamine 1 mg followed by remifentanil.

Drug: Ketamine 1Drug: Remifentanil

ketamine 2

EXPERIMENTAL

Anesthesia induction with ketamine 2 mg followed by remifentanil.

Drug: Ketamine 2Drug: Remifentanil

Interventions

Anesthesia induction is performed with 1 mg ketamine.

ketamine 1

Anesthesia induction is performed with 2 mg ketamine.

ketamine 2

After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.

ketamine 1ketamine 2

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA I-II
  • Undergoing general anesthesia with endotracheal tube

You may not qualify if:

  • Anticipated difficult airway
  • Patient with upper respiratory infection within 14 days
  • Asthma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajou universitiy school of medicine

Suwon, Gyeong-gi Do, 16499, South Korea

Location

MeSH Terms

Interventions

Remifentanil

Intervention Hierarchy (Ancestors)

PropionatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • yun jeong chae, Ph.D

    Ajou University School of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 8, 2016

First Posted

January 14, 2016

Study Start

June 19, 2017

Primary Completion

April 16, 2018

Study Completion

April 16, 2018

Last Updated

January 10, 2019

Record last verified: 2019-01

Locations